Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Airflow Limitation”

Showing 8 of 0 results

Post-approval studies (Phase 4)Active Not RecruitingNCT02797275
What this trial is testing

Secondhand Smoke Respiratory Health Study

Who this might be right for
Secondhand SmokeAir TrappingTobacco+3 more
University of California, San Francisco 107
Not applicableEnded earlyNCT03592212
What this trial is testing

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood Asthma

Who this might be right for
Asthma
Assistance Publique - Hôpitaux de Paris 99
Not applicableStudy completedNCT01695265
What this trial is testing

Feel Breathe, Restriction Device Ventilatory Nasal (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Cadiz 20
Large-scale testing (Phase 3)WithdrawnNCT01834885
What this trial is testing

A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Ended earlyNCT04204252
What this trial is testing

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Kamada, Ltd. 98
Large-scale testing (Phase 3)WithdrawnNCT01860066
What this trial is testing

A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT03263130
What this trial is testing

Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap

Who this might be right for
COPD, Emphysema, Asthma COPD OverlapEmphysema
Gelb, Arthur F., M.D. 60
Not applicableLooking for participantsNCT07315958
What this trial is testing

Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology Clinics

Who this might be right for
Respiratory (Chronic Obstructive Pulmonary Disease)
AstraZeneca 1,000

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation